UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 3 |
Visa
V
|
+$141M |
| 4 |
Alibaba
BABA
|
+$137M |
| 5 |
Freeport-McMoran
FCX
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$196M |
| 2 |
Infosys
INFY
|
+$163M |
| 3 |
Monster Beverage
MNST
|
+$144M |
| 4 |
Mastercard
MA
|
+$128M |
| 5 |
Procter & Gamble
PG
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14.28% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Edison International
EIX
$27.4B
| $69.8M | 0.07% |
1,248,285
+18,313
| +1% | +$1.05M |
|
302
Alcoa
AA
$12.3B
| $69.7M | 0.07% |
1,802,018
+82,549
| +5% | +$3.24M |
|
|
CTLT
303
DELISTED
CATALENT, INC.
CTLT
| $69.6M | 0.07% |
+2,782,546
| New | +$61.5M |
|
304
Chipotle Mexican Grill
CMG
$47B
| $68.5M | 0.07% |
5,136,800
+180,500
| +4% | +$2.37M |
|
305
WEC Energy
WEC
$35.1B
| $68M | 0.07% |
1,580,680
+32,696
| +2% | +$1.45M |
|
306
Vanguard Russell 1000 ETF
VONE
$8.44B
| $67.8M | 0.07% |
746,741
+228,905
| +44% | +$20.9M |
|
307
PACCAR
PCAR
$68.5B
| $67.4M | 0.07% |
1,778,864
+57,435
| +3% | +$2.39M |
|
|
CMCSK
308
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $67.1M | 0.07% |
1,254,980
-3,993
| -0.3% | -$214K |
|
309
Verisk Analytics
VRSK
$25.1B
| $67M | 0.07% |
1,100,520
+111,668
| +11% | +$6.97M |
|
310
Jabil
JBL
$34.5B
| $66.9M | 0.07% |
3,315,943
+169,853
| +5% | +$3.55M |
|
311
Analog Devices
ADI
$181B
| $65.8M | 0.07% |
1,329,082
+25,739
| +2% | +$1.32M |
|
312
Bankunited
BKU
$3.43B
| $65.6M | 0.07% |
2,151,277
-115,800
| -5% | -$3.69M |
|
313
Fidelity National Information Services
FIS
$20.5B
| $65.3M | 0.06% |
1,159,959
+5,026
| +0.4% | +$284K |
|
314
Nucor
NUE
$60.1B
| $65.2M | 0.06% |
1,201,719
+45,120
| +4% | +$2.38M |
|
315
Edwards Lifesciences
EW
$51.2B
| $65.2M | 0.06% |
3,828,264
+899,916
| +31% | +$14.2M |
|
316
Zimmer Biomet
ZBH
$18.4B
| $65.2M | 0.06% |
667,463
-53,132
| -7% | -$5.23M |
|
317
Agilent Technologies
A
$39.5B
| $65.1M | 0.06% |
1,597,233
+41,670
| +3% | +$1.7M |
|
318
Weyerhaeuser
WY
$17.9B
| $64.8M | 0.06% |
2,034,695
-30,400
| -1% | -$997K |
|
319
Zoetis
ZTS
$31.8B
| $64.5M | 0.06% |
1,745,356
+59,964
| +4% | +$2.05M |
|
320
Bio-Rad Laboratories Class A
BIO
$8.91B
| $64.5M | 0.06% |
568,595
-17,180
| -3% | -$2.04M |
|
|
VRN
321
DELISTED
Veren
VRN
| $64.1M | 0.06% |
1,915,701
+432,420
| +29% | +$16M |
|
322
Sabre
SABR
$799M
| $64M | 0.06% |
3,571,100
+41,700
| +1% | +$785K |
|
|
MJN
323
DELISTED
Mead Johnson Nutrition Company
MJN
| $63.8M | 0.06% |
662,690
+10,221
| +2% | +$968K |
|
324
Xerox
XRX
$425M
| $63.8M | 0.06% |
1,828,898
+5,099
| +0.3% | +$178K |
|
|
MDVN
325
DELISTED
MEDIVATION, INC.
MDVN
| $63.7M | 0.06% |
1,289,496
-84,836
| -6% | -$3.6M |
|
Similar funds
UBS AM's Q3 2014 Portfolio in Review
As of Q3 2014, UBS AM held 2,623 positions worth $101B, up 1.8% from $99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q3 2014 filing shows 68 new, 1,056 increased, 515 reduced and 65 closed positions. Its largest new stake was Alibaba: 1,521,250 shares worth $135M. The largest sale was Kellanova, an estimated $196M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q3 2014 buy was Alibaba: 1,521,250 shares worth $135M.
- UBS AM added most to Apple in Q3 2014, an estimated $204M increase.
- UBS AM's biggest Q3 2014 reduction was Kellanova, cutting an estimated $196M.
- UBS AM fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $80.9M.
- UBS AM's ten largest holdings make up 15% of its $101B portfolio in Q3 2014.
- UBS AM opened 68 new positions and closed 65 in Q3 2014.
- UBS AM's portfolio value rose 1.8% quarter-over-quarter to $101B.
Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.